Mask group

Diagnostic Categories Include:

  • Mask group
    Depressive Disorders
  • Mask group
    ADHD & Disruptive Behavior Disorders
  • Mask group
    Impulse Control Disorders
  • Mask group
    Autistic Spectrum Disorders
  • Capital Region Outpatient Wellness Network
    Anger Management
  • Mask group
    Post-traumatic Stress Disorder
  • Mask group
    Bipolar Disorders
  • Mask group
    Transcranial Magnetic Stimulation (TMS)
  • Mask group
    Anxiety Disorders
  • Capital Region Outpatient Wellness Network
    Schizophrenia Disorders
  • Capital Region Outpatient Wellness Network
    Eating Disorders
  • Capital Region Outpatient Wellness Network
    Learning Disorders
Book a Consultation

Contact Us

Feeling overwhelmed and looking for support? Book a consultation with our caring team, who are dedicated to understanding your unique needs and guiding you towards a healthier, happier life. We’re here to help you every step of the way.

    CROWN - SMHANeuroStar_Logo

    Adult Indications for Use
    The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

    The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

    Adolescent Indications for Use
    NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).

    NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.

    Important Safety Information
    The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).

    NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.